[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-281877-105":53,"doc-detail-281877-en":127},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":120,"head_meta":122,"extra_data":124,"updated_unix":126},105,"en","sop-14-distribution-of-study-income-version-9","SOP 14 - Distribution of Study Income - Version 9","","Standard Operating Procedure SOP 14 defines how clinical trials and research projects achieve cost-neutrality for the hosting Gloucestershire Hospitals NHS Foundation Trust. It sets out the review process used by the Research, Innovation and Genomics (RIG) Team to ensure adequate funding based on study-specific costings and whether studies are adopted to the NIHR Portfolio. The SOP describes procedures for reviewing study costs, distributing income for commercial and noncommercial studies, and the responsibilities of investigators, local collaborators, divisional management, and Trust finance staff.",{"@graph":63,"@context":119},[64,80,102],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":11,"@type":70,"position":76},"https://docshare.wps.com/template/presentations/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/sop-14-distribution-of-study-income-version-9/281877/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/sop-14-distribution-of-study-income-version-9/281877.png","ImageObject",442,249,{"name":88,"@type":89},"Aladdin","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-22","2026-09-16",true,{"@type":98,"interactionType":99,"userInteractionCount":101},"InteractionCounter",{"@type":100},"ViewAction",10,{"@type":103,"mainEntity":104},"FAQPage",[105,111,115],{"name":106,"@type":107,"acceptedAnswer":108},"What is the purpose of SOP 14 on study income distribution?","Question",{"text":109,"@type":110},"SOP 14 sets the process for reviewing study costs and distributing income from commercial and noncommercial studies while ensuring projects are cost-neutral for the hosting trust.","Answer",{"name":112,"@type":107,"acceptedAnswer":113},"Who must follow SOP 14 when a new study seeks approval?",{"text":114,"@type":110},"The GHNHSFT RIG Team follows the SOP, while Chief Investigators, Principal Investigators, and Local Collaborators adhere to the costing model and provide recruitment activity accounts to support invoicing calculations.",{"name":116,"@type":107,"acceptedAnswer":117},"How does the SOP determine how income is distributed?",{"text":118,"@type":110},"Income and costings vary by study, including whether the study is adopted to the NIHR Portfolio, and SOP 14 provides the steps for assessing costs and allocating study income accordingly.","https://schema.org",{"og:url":78,"og:type":121,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":123,"canonical":78},"index,follow",{"doc_id":125,"site_id":56},281877,1791321218,{"code":4,"msg":5,"data":128},{"doc_id":125,"user_id":129,"nickname":88,"user_avatar":130,"doc_module":9,"category_id":8,"category_name":11,"doc_title":59,"doc_description":61,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":101,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":30,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":140,"read_time":141},2336478503145,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","SOP 14: Distribution of Study Income  \n\n| SOP reference: | SOP 14 |  |  |\n| --- | --- | --- | --- |\n| Version: | 9.0 |  |  |\n| Author: | Chris Ford |  | |\n| Approved by Trust Senior Responsible Officer for RIG: | Noel Peter |  | |\n|  | 08/07/2026 |  |  |\n| Implementation date of current version: |  | 12/08/2026 |  |\n| Date of Review: |  | 12/08/2029 |  |\n\nIT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO ENSURE THAT THE CORRECT VERSION IS BEING USED  \nAll staff should regularly check the Research Webpage for information relating to the implementation of new or revised versions. Staff must ensure that they are adequately trained in the new procedure and must make sure that all copies of superseded version are promptly withdrawn from use unless notified otherwise by the SOP Controller.  \nThe definitive version of all Gloucestershire Hospitals NHS Foundation Trust SOPs appear online. If you are reading this in printed form, check that the version number and date below is the most recent one as shown on the Research website:  \n[https://www.gloshospitals.nhs.uk/about-us/research-our-hospitals](https://www.gloshospitals.nhs.uk/about-us/research-our-hospitals)  \nThe Gloucestershire Hospitals NHS Foundation Trust wishes to acknowledge York Hospitals NHS Foundation Trust and University Hospitals Bristol NHS Foundation Trust who gave permission to use their templates in the development of these SOPs.  \n© Gloucestershire Hospitals NHS Foundation Trust 2025  \nNo part of this document may be reproduced or transmitted in any form or by any means without the prior permission of the Gloucestershire Hospitals NHS Foundation Trust  \nVersion History Log  \nThis area will be updated with details of all changes made to the SOP whether due for full review or not.  \n\n| Version | Details of Change | Date\u003Cbr>Implemented |\n| --- | --- | --- |\n| 1.0 | Original SOP was R&D 16 | 06/12/2013 |\n| 1.1 | Updating typographical errors and layout | 09/12/2014 |\n| 2.0 | Reviewed and updated along with reorganisation into the Gloucestershire R&D Consortium suite of SOPs | 22/11/2016 |\n| 3.0 | Change of priority for the monies generated from commercial trials (GHNHSFT) | 19/07/2017 |\n| 4.0 | Rebranding to GHNHSFT, updating contact details and reference documents | 31/03/2018 |\n| 5.0 | See section 6-clarification of what signed agreements / Summary of Activities / Trust C&C will be required See section 9.1.2 payments for running Commercial trials rewording for clarification\u003Cbr>See section 9.2 Indirect cost allocation rewording for clarification | Xx/06/2018 Not implemented |\n| 6.0 | Change of SOP title\u003Cbr>Correction of typographical errors\u003Cbr>Implementation of the NCVR process\u003Cbr>Removal of non NHIR costing template appendix Removal of SOP categories and change of reference codes\u003Cbr>Change to the income distribution model Departmental name change to R&I from R&D Insertion of webpage for NCVR\u003Cbr>Clarification of PI allocation of indirect costs | 13/05/2024 |\n| 7.0 | Further clarification of indirect costs\u003Cbr>Inclusion of use of iCT on EDGE and Template NCVR escalation email | 01/10/2024 |\n| 8.0 | Further updates regarding the NCVR review and escalation process. Including further details on noncommercial costs as not previously covered | 24/11/2025 |\n| 9.0 | Change to the Indirect cost split\u003Cbr>Information regarding externally sponsored non-portfolio non-commercial studies\u003Cbr>Change to departmental email address | 12/08/2026 |\n\nThis SOP will be reviewed every three years unless changes to any relevant  \nlegislation require otherwise  \nGlossary  \n\n| CI | Chief Investigator |\n| --- | --- |\n| CTA | Clinical Trial Agreement |\n| EDGE | Clinical Trials IT management system |\n| GHNHSFT | Gloucestershire Hospitals NHS Foundation Trust |\n| GOG | Governance Oversight Group |\n| ICB | Integrated Care Board |\n| iCT | interactive Costing Tool |\n| LC | Local Collaborators |\n| MCTA | Model Clinical Trial Agreement |\n| MFF | Market Forces Factor |\n| NCVR | National Contract Value Re","cbCaipDMw47EakJU","https://ap.wps.com/l/cbCaipDMw47EakJU","pdf",740215,"English","# 1. Introduction, Background and Purpose\n## Cost-neutrality and funding review\n# 2. Who should use this SOP?\n## Roles of CI, PI, and Local Collaborators\n# 3. When this SOP should be Used?\n# 4. Costings\n# 5. Checking Commercial Costs\n# 6. Clinical Trial Agreements\n# 7. Invoicing\n# 8. Components of Study Income\n# 9. Income Distribution\n# 10. References\n## Appendix 1: NIHR costing template terminology\n## Appendix 2: Template NCVR escalation email","[{\"question\":\"What is the purpose of SOP 14 on study income distribution?\",\"answer\":\"SOP 14 sets the process for reviewing study costs and distributing income from commercial and noncommercial studies while ensuring projects are cost-neutral for the hosting trust.\"},{\"question\":\"Who must follow SOP 14 when a new study seeks approval?\",\"answer\":\"The GHNHSFT RIG Team follows the SOP, while Chief Investigators, Principal Investigators, and Local Collaborators adhere to the costing model and provide recruitment activity accounts to support invoicing calculations.\"},{\"question\":\"How does the SOP determine how income is distributed?\",\"answer\":\"Income and costings vary by study, including whether the study is adopted to the NIHR Portfolio, and SOP 14 provides the steps for assessing costs and allocating study income accordingly.\"}]","SOP 14 - Distribution of Study Income - Version 9 | PDF",1789568757,6]